glycine in tirzepatide Apple glycine with tirzepatide Tirzepatide w/

Application note about determining Kd for the glucagon GLP-1 receptor with Tag-lite HTRF technology.

Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces

Wondering when to take metformin

Conclusion Exposures to glucagon-like peptide-1 receptor agonist have increased substantially over the years

Discover the risks, including pancreatitis and gallbladder issues, linked to extended use.

Adults with obesity and type 2 diabetes achieved a 14.7% weight loss at 72 weeks with 15 mg tirzepatide, according to data from the SURMOUNT-2 trial presented at the American Diabetes Association Scientific Sessions.In a phase 3 randomized controlled trial, more than 60% of adults with obesity and type 2 diabetes lost at least 10% of their body weight at 72 weeks if they were